Aptevo Therapeutics Inc. SEC filings APVO
Aptevo Therapeutics Inc. has 740 filings in SEC EDGAR's recent list, going back to Apr 15, 2016. Its latest annual report, Form ARS, was filed on Jul 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 30, 2026 | — |
| S-8 | Employee stock plan registration | Sep 25, 2026 | — |
| 424B4 | Prospectus | Sep 3, 2026 | — |
| S-1 | Registration statement | Aug 21, 2026 | — |
| S-8 | Employee stock plan registration | Jul 24, 2026 | — |
| 424B4 | Prospectus | Jan 30, 2026 | — |
| S-1 | Registration statement | Jan 28, 2026 | — |
| 424B4 | Prospectus | Nov 25, 2025 | — |
| S-1 | Registration statement | Oct 1, 2025 | — |
| 424B4 | Prospectus | Aug 8, 2025 | — |
| S-1 | Registration statement | Jul 25, 2025 | — |
| 424B5 | Prospectus supplement | Jun 20, 2025 | — |
| 424B4 | Prospectus | Jun 20, 2025 | — |
| S-1MEF | Filing | Jun 18, 2025 | — |
| S-1 | Registration statement | Jun 16, 2025 | — |
| 424B3 | Prospectus | May 28, 2025 | — |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| S-1 | Registration statement | May 13, 2025 | — |
| S-3 | Shelf registration | May 2, 2025 | — |
| 424B5 | Prospectus supplement | Apr 29, 2025 | — |
| 424B4 | Prospectus | Apr 28, 2025 | — |
| 424B4 | Prospectus | Apr 22, 2025 | — |
| 424B4 | Prospectus | Apr 4, 2025 | — |
| S-1/A | Amended registration statement | Apr 1, 2025 | — |
| S-1/A | Amended registration statement | Mar 27, 2025 | — |
| S-1/A | Amended registration statement | Mar 27, 2025 | — |
| S-1/A | Amended registration statement | Mar 25, 2025 | — |
| S-1 | Registration statement | Mar 3, 2025 | — |
| S-3 | Shelf registration | Feb 14, 2025 | — |
| S-3 | Shelf registration | Dec 20, 2024 | — |
| 424B4 | Prospectus | Sep 17, 2024 | — |
| S-1 | Registration statement | Aug 30, 2024 | — |
| S-8 | Employee stock plan registration | Jul 12, 2024 | — |
| 424B4 | Prospectus | Jun 28, 2024 | — |
| S-1/A | Amended registration statement | Jun 26, 2024 | — |
| S-1 | Registration statement | Jun 14, 2024 | — |
| 424B4 | Prospectus | Apr 12, 2024 | — |
| S-1/A | Amended registration statement | Apr 9, 2024 | — |
| S-1/A | Amended registration statement | Mar 29, 2024 | — |
| S-1 | Registration statement | Mar 20, 2024 | — |
| S-3 | Shelf registration | Nov 22, 2023 | — |
| 424B4 | Prospectus | Aug 3, 2023 | — |
| S-1/A | Amended registration statement | Aug 1, 2023 | — |
| S-1/A | Amended registration statement | Jul 14, 2023 | — |
| S-1 | Registration statement | Jun 30, 2023 | — |
| S-8 | Employee stock plan registration | Jun 7, 2022 | — |
| 424B5 | Prospectus supplement | Mar 29, 2022 | — |
| 424B5 | Prospectus supplement | Mar 24, 2022 | — |
| 424B5 | Prospectus supplement | Feb 18, 2022 | — |
| S-3 | Shelf registration | Aug 12, 2021 | — |
| S-3 | Shelf registration | Dec 14, 2020 | — |
| 424B5 | Prospectus supplement | Aug 12, 2019 | — |
| 424B5 | Prospectus supplement | Mar 8, 2019 | — |
| 424B5 | Prospectus supplement | Mar 6, 2019 | — |
| 424B5 | Prospectus supplement | Feb 13, 2019 | — |
| S-3 | Shelf registration | Jan 2, 2019 | — |
| S-8 | Employee stock plan registration | Aug 9, 2018 | — |
| S-3/A | Amendment no.1 to form s-3 | Dec 6, 2017 | — |
| S-3 | Shelf registration | Nov 13, 2017 | — |
| S-8 | Employee stock plan registration | Aug 10, 2017 | — |
| S-8 | Employee stock plan registration | Aug 12, 2016 | — |
Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APVO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Seattle, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1671584
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.